Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: Ticagrelor vs Clopidogrel Effect on MFR in CAD Population [Phase 2, Phase 3]

View source ↗

Summary

This document reports a completed Phase 2/Phase 3 clinical trial comparing ticagrelor versus clopidogrel on microvascular function in patients with coronary art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED